Development of a new purified vero cell rabies vaccine (Rabivax-S) at the serum institute of India Pvt Ltd
Introduction: Rabies is a 100% fatal disease with significant disease burden in Asia and Africa but preventable with vaccines and immunoglobulins. There are very few WHO prequalified cell culture derived rabies vaccines available globally for use in humans. We have developed a new purified vero cell...
Main Authors: | Prasad S. Kulkarni, Ashish Sahai, Bhagwat Gunale, Rajeev M Dhere |
---|---|
格式: | 文件 |
语言: | English |
出版: |
Taylor & Francis Group
2017-04-01
|
丛编: | Expert Review of Vaccines |
主题: | |
在线阅读: | http://dx.doi.org/10.1080/14760584.2017.1294068 |
相似书籍
-
Immunogenicity and safety of WHO-approved TRC-ID regimen with a chromatographically purified Vero cell rabies vaccine with or without rabies immunoglobulin in children
由: Piyada Angsuwatcharakon, et al.
出版: (2018-02-01) -
Safety and immunogenicity of freeze-dried human rabies vaccines: A phase 3 clinical trial of Zagreb and Essen regimes
由: Jia Li, et al.
出版: (2024-12-01) -
Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine
由: D.J. Briggs, et al. -
Immunogenicity and safety of purified vero cell rabies vaccine (PVRV) produced by Liaoning Cheng Da Co. under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese adults aged 50 and above
由: Jing Wang, et al.
出版: (2017-01-01) -
DETERMINATION OF THE RABIES VIRUS-INFECTED VERO LINE CELL PORTION BY FLOW CYTOMETRY
由: A. L. Kravtsov, et al.
出版: (2019-08-01)